Rilmazolam is a triazolobenzodiazepine and the principal active metabolite of rilmazafone, a prodrug sold under the brand name Rhythmy (リスミー) in Japan and approved there for the treatment of insomnia and as a pre-anesthetic agent.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.